Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing

Recruiting N/A Interventional Study
Genetic Predisposition to Disease Genetic Predisposition
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 39
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
40 (estimated)
Sponsor
Dana-Farber Cancer Institute · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This research is being done to develop the electronic platform Nest for young adults (ages 18-39) who have had prior cancer genetic testing. The platform will give patients and their clinicians access to continuously updated information about both pathogenic variants and variants of uncertain significance (VUS). The name of the intervention used in this research study is: Nest portal (electronic…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria AIM 1: * YA Patients: * Ages 18-39 years, inclusive. * Has had previous cancer genetic testing, with a finding of a pathogenic variant or VUS; patient has previously received results from the clinical team. * English-speaking and -reading. * Receiving care at DFCI. * N…
Contacts

Jennifer Mack, MD

617-632-6818

Jennifer_mack@dfci.harvard.edu

CONTACT